TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype

被引：15

作者：

Hiwase, Devendra ^{[1
,2
,3
,4
,5
]}

Hahn, Christopher ^{[4
,5
,7
]}

Tran, Elizabeth Ngoc Hoa ^{[2
,3
]}

Chhetri, Rakchha ^{[1
,2
,3
]}

Baranwal, Anmol ^{[6
]}

Al-Kali, Aref ^{[6
]}

Sharplin, Kirsty ^{[1
]}

Ladon, Dariusz ^{[7
]}

Hollins, Rachel ^{[7
]}

Greipp, Patricia ^{[8
]}

Kutyna, Monika ^{[1
,2
,3
]}

Alkhateeb, Hassan ^{[6
]}

Badar, Talha ^{[9
]}

Wang, Paul ^{[10
]}

Ross, David M. ^{[1
,2
,3
,4
,5
]}

Singhal, Deepak ^{[1
,2
]}

Shanmuganathan, Naranie ^{[1
,2
]}

Bardy, Peter ^{[1
]}

Beligaswatte, Ashanka ^{[1
]}

Yeung, David ^{[1
,2
]}

Litzow, Mark R. ^{[6
]}

Mangaonkar, Abhishek ^{[6
]}

Giri, Pratyush ^{[1
]}

Lee, Cindy ^{[1
]}

Yong, Angie ^{[1
]}

Horvath, Noemi ^{[1
]}

Singhal, Nimit ^{[1
]}

Gowda, Raghu ^{[1
]}

Hogan, William ^{[6
]}

Gangat, Naseema ^{[6
]}

Patnaik, Mrinal ^{[6
]}

Begna, Kebede ^{[6
]}

Tiong, Ing S. ^{[11
,12
]}

Wei, Andrew ^{[11
,12
]}

Kumar, Sharad ^{[4
,5
]}

Brown, Anna ^{[4
,5
,7
]}

Scott, Hamish ^{[4
,5
,7
]}

Thomas, Daniel ^{[1
,2
,3
]}

Kok, Chung H. ^{[2
,3
]}

Tefferi, Ayalew ^{[6
]}

Shah, Mithun Vinod

机构：

[1] Royal Adelaide Hosp, Cent Adelaide Local Hlth Network, Dept Haematol, Adelaide, SA, Australia

[2] South Australian Hlth & Med Res Inst SAHMRI, Precis Med Theme, Adelaide, SA, Australia

[3] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia

[4] Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia

[5] SA Pathol, Adelaide, SA, Australia

[6] Mayo Clin Rochester, Div Hematol, Rochester, MN 55906 USA

[7] SA Pathol, Genet & Mol Pathol, Adelaide, SA, Australia

[8] Mayo Clin Rochester, Lab Med & Pathol, Rochester, MN 55906 USA

[9] Mayo Clin Jacksonville, Dept Hematol Oncol, Jacksonville, FL USA

[10] SA Pathol, ACRF Canc Genom Facil, Adelaide, SA, Australia

[11] Alfred Hosp, Dept Haematol, Melbourne, Vic, Australia

[12] Monash Univ, Melbourne, Vic, Australia

来源：

BLOOD | 2023年 / 141卷 / 09期

基金：

澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;

关键词：

D O I：

10.1182/blood.2022018236

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1087 / 1091

页数：5

共 50 条

[1] TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome
Shah, Mithun, V
Hahn, Christopher N.
Tran, Elizabeth Ngoc Hoa
Sharplin, Kirsty M.
Chhetri, Rakchha
Baranwal, Anmol
Kutyna, Monika M.
Wang, Paul
Ladon, Dariusz
Al-Kali, Aref
Alkhateeb, Hassan B.
Ross, David M.
Yeung, David T.
Shanmuganathan, Naranie
Litzow, Mark R.
Mangaonkar, Abhishek A.
Hogan, William J.
Gangat, Naseema
Patnaik, Mrinal M. M.
Kebede, Begna
Kumar, Sharad
Singhal, Deepak
Brown, Anna L.
Scott, Hamish S.
Thomas, Daniel
Kok, Chung Hoow
Tefferi, Ayalew
Hiwase, Devendra
BLOOD, 2022, 140 : 9798 - 9799
[2] Preexisting TP53 mutation in therapy-related acute myeloid leukemia
Schulz, Eduard
Kashofer, Karl
Heitzer, Ellen
Mhatre, Ketaki N.
Speicher, Michael R.
Hoefler, Gerald
Sill, Heinz
ANNALS OF HEMATOLOGY, 2015, 94 (03) : 527 - 529
[3] Preexisting TP53 mutation in therapy-related acute myeloid leukemia
Eduard Schulz
Karl Kashofer
Ellen Heitzer
Ketaki N. Mhatre
Michael R. Speicher
Gerald Hoefler
Heinz Sill
Annals of Hematology, 2015, 94 : 527 - 529
[4] TP53 and therapy-related myeloid neoplasms
Chung, Jae
Sallman, David A.
Padron, Eric
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (01) : 98 - 103
[5] Therapy-related myeloid neoplasm in a patient with TP53 mutation: a dilemma in allogeneic stem cell transplant
Kim, Min Kyoung
Cho, Hee Soon
Bae, Young Kyung
Lee, Kyung Hee
Ki, Chang-Seok
Lee, Seung-Tae
Hyun, Myung Soo
LEUKEMIA & LYMPHOMA, 2010, 51 (06) : 1144 - 1147
[6] TP53 Allelic Status in TP53 Mutated Therapy-Related Myeloid Neoplasms is Inconsequential
Zak, Taylor
Sukhanova, Madina
Gao, Juehua
Behdad, Amir
Chen, Yi-Hua
Chen, Qing
Tariq, Hamza
LABORATORY INVESTIGATION, 2024, 104 (03) : S1520 - S1522
[7] Hypomethylating Therapy Does Not Improve Outcome of Therapy-Related Myeloid Neoplasm Including TP53 Mutated and Complex Karyotype SubgroupsHypomethylating Therapy Does Not Improve Outcome of Therapy-Related Myeloid Neoplasm Including TP53 Mutated and Complex Karyotype Subgroups
Chhetri, Rakchha
Sharplin, Kirsty
Proudman, William
Kutyna, Monika M.
Nayar, Siddarth
Singhal, Deepak
Ross, David M.
Damin, Michelle
Kalro, Akash
Bardy, Peter G.
Thomas, Daniel
Shah, Mithun V.
Hiwase, Devendra
BLOOD, 2021, 138 : 3702 - +
[8] TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML
Weinberg, Olga K.
Siddon, Alexa
Madanat, Yazan F.
Gagan, Jeffrey
Arber, Daniel A.
Dal Cin, Paola
Narayanan, Damodaran
Ouseph, Madhu M.
Kurzer, Jason H.
Hasserjian, Robert P.
BLOOD ADVANCES, 2022, 6 (09) : 2847 - 2853
[9] TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms
Shah, Mithun Vinod
Tran, Elizabeth Ngoc Hoa
Shah, Syed
Chhetri, Rakchha
Baranwal, Anmol
Ladon, Dariusz
Shultz, Carl
Al-Kali, Aref
Brown, Anna L.
Chen, Dong
Scott, Hamish S.
Greipp, Patricia
Thomas, Daniel
Alkhateeb, Hassan B.
Singhal, Deepak
Gangat, Naseema
Kumar, Sharad
Patnaik, Mrinal M.
Hahn, Christopher N.
Kok, Chung Hoow
Tefferi, Ayalew
Hiwase, Devendra K.
BLOOD CANCER JOURNAL, 2023, 13 (01)
[10] TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms
Mithun Vinod Shah
Elizabeth Ngoc Hoa Tran
Syed Shah
Rakchha Chhetri
Anmol Baranwal
Dariusz Ladon
Carl Shultz
Aref Al-Kali
Anna L. Brown
Dong Chen
Hamish S. Scott
Patricia Greipp
Daniel Thomas
Hassan B. Alkhateeb
Deepak Singhal
Naseema Gangat
Sharad Kumar
Mrinal M. Patnaik
Christopher N. Hahn
Chung Hoow Kok
Ayalew Tefferi
Devendra K. Hiwase
Blood Cancer Journal, 13

← 1 2 3 4 5 →